This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Hedgehog, Inc., Kookmin University Industry Academy Cooperation Foundation, Korea University Research and Business Foundation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 17 
1 out of 1,274 Years Active: 2025-2026
Title: Innovations of Jung-Hyun Na in Antibody Development
Introduction
Jung-Hyun Na is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on addressing critical health issues such as hypertension and cancer.
Latest Patents
Jung-Hyun Na holds a patent for an "Endothelin receptor type A activity regulating antibody." This invention relates to a monoclonal antibody or a fragment that specifically recognizes and binds to the extracellular domain of endothelin receptor type A. The monoclonal antibody is designed for use as a therapeutic agent for conditions associated with endothelin receptor type A, including hypertension and cancer.
Career Highlights
Jung-Hyun Na is associated with Hedgehog, Inc., where he continues to innovate and develop new therapeutic solutions. His expertise in monoclonal antibodies has positioned him as a key figure in the biotechnology sector.
Collaborations
He collaborates with notable colleagues, including Sang Taek Jung and Yeon Gyu Yu, who contribute to his research and development efforts.
Conclusion
Jung-Hyun Na's work exemplifies the impact of innovative research in biotechnology, particularly in creating targeted therapies for serious health conditions. His contributions are paving the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile